We previously discovered that high expression of TRPC5 in CRC cells was related to drug resistance (Wang et al., 2015), while high expression of TRPC5 in CRC tissues was related to a worse prognosis (Chen et al., 2017). The gene discussed is TRPC5; the disease is colorectal carcinoma.